Azelis Group stock
Price history
+29.72% over the period1 year: from €9.23 (November 17, 2025) to €11.98 (November 16, 2026), +29.72%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 16, 2026 | €11.98 |
| October 30, 2026 | €11.71 |
| September 30, 2026 | €12.09 |
| August 31, 2026 | €12.43 |
| July 31, 2026 | €11.31 |
| June 30, 2026 | €9.31 |
| May 29, 2026 | €9.85 |
| April 30, 2026 | €11.28 |
| March 31, 2026 | €8.68 |
| February 27, 2026 | €8.40 |
| January 30, 2026 | €8.36 |
| December 31, 2025 | €9.35 |
| November 28, 2025 | €9.28 |
| November 17, 2025 | €9.23 |
At a glance
The company
Distribute specialty chemicals and food ingredients for life sciences, healthcare, nutrition and industrial applications across Europe, Middle East, Africa, Americas and Asia-Pacific
Latest results
Quarter to September 30, 2026
Next event
TickerLandia's take on Azelis Group
- Priced as usual relative to earnings: P/E on the latest fiscal year 26 vs a median of 29 over its last 5 fiscal years.
- Priced in line with similar companies: trailing 12-month P/E 26 vs 26 (+0%) in a group of 9.
- Strong point: Earnings stability (78/100 in its group). Weak point: Profitability (22/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−11.72% from the 52-week high
Analysts · 14 analysts
Average target€13.68+14.15% vs. price
Buy 7 · Hold 7 · Sell 0 · Buy
TickerLandia Fingerprint: Azelis Group
Compared with similar companies: high earnings stability, low profitability, and strong momentum.
Financials and price compared with 59 companies in the specialty chemicals industry, worldwide. Momentum and risk compared with 1,160 European stocks.
Pricelow32
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 25.7 52 Forward P/E 13.3 25 Price/book 1.04 20 EV/EBITDA 11.0 43 Price/sales 0.71 18 Profitabilitylow22
How much it earns on revenue and capital.
Metric Value Position in group ROE 4.1% 21 Operating margin 7.8% 23 ROA 3.5% 30 Gross margin 23.2% 19 Net margin 2.7% 18 Earnings stabilityhigh78
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 0.8% 91 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 65 Growthlow36
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +0.01% 48 Earnings growth (year over year) +2.90% 47 Revenue growth (year over year) +0.30% 13 Financial strengthlow32
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Debt/equitycounts in reverse: lower means more financial strength 0.65 47 Net debt/EBITDAcounts in reverse: lower means more financial strength 3.95 9 Interest coverage 3.26 14 Current ratio 1.87 59 Dividendlow34
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years at least 5 years 9 Payout ratio 48.1% 47 Dividend yield 1.9% 45 Market momentumstrong71
How the stock has moved compared with the market.
Metric Value Position in group Distance from 200-day average +14.29% 78 1-year return +21.06% 64 Riskhigh67
How much the price swings.
Metric Value Position in group Maximum drawdown (12 months) 31.0% 71 Volatility (60 days) 30.5% 62
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Azelis Group is priced as in the past and in line with similar companies
On the latest fiscal year's earnings (2025), Azelis Group's P/E today is 26.2, in line with the median of its last 5 fiscal years (29.1; between 20.5 and 87.1 from 2021 to 2025). Azelis Group's P/E (trailing 12 months): 25.7, in line with the median of a group of 9 similar companies (25.7).
Compared with 9 similar companies
| Metric | Azelis Group | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 25.7 | Middle | |
| Forward P/E | 13.3 | Middle | |
| Operating margin | 7.8% | Low | |
| ROE | 4.1% | Middle | |
| Debt/equity | 0.65 | Middle |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Azelis Group. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
€2.17B
Latest quarter · Q2 2026
Net income
€85.16M
Latest quarter · Q2 2026
Quarterly net margin
3.9%
Latest quarter · Q2 2026
Numbers and valuation
Full valuation- Market cap
- €2.94B
- P/E
- 25.7
- EPS
- €0.47
- Volume
- 217.55K
- Daily trading
- €2.47M
- Dividend yield
- 1.89%
- Last ex-dividend on June 29, 2026
How Azelis Group is changing
All resultsRevenue grew 13.1% a year on average over the last 5 years
Operating margin fell from 9.7% to 7.9%
Shares outstanding down 79.3% in 5 years
Returns
Azelis Group returns with dividends
€1,000 invested in Azelis Group 5 years ago, on November 16, 2021, would be worth €470 today with dividends reinvested: −53.01% in total, −14.02% per year. On price alone it would be €439 (−56.08%).
| Period | Azelis Group | €1,000 becomes |
|---|---|---|
| 1 month | −10.60% | €894 |
| 6 months | +12.17% | €1,122 |
| Year to date | +28.13% | €1,281 |
| 1 year | +32.79% | €1,328 |
| 3 years | −36.11% | €639 |
| 5 years | −53.01% | €470 |
From 1 year up with dividends reinvested, before taxes; under a year price only. Calculate your investment
The chart in detail
Azelis Group: technical analysis
Azelis Group shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 57.8% below its all-time closing high (€28.40, November 9, 2021).
- Trend
- No clear trend
- RSI (14 sessions)
- 49
- Between 30 and 70
- vs 200-session average
- +13.28%
Support and resistance
Price areas where Azelis Group has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance€12.58+5.01%2 touches, last on September 2, 2026
- Resistance€12.15+1.44%4 touches, last on November 5, 2026
- Last price€11.98
- Support€11.67−2.62%3 touches, last on September 15, 2026
- Support€11.42−4.70%3 touches, last on October 28, 2026
- Support€10.26−14.36%3 touches, last on July 21, 2026
Volatility and risk
- Volatility (60 sessions, annualised)
- 30.3%
- Largest fall in the last year
- −31.03%
In session, November 16, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Azelis Group: seasonality
Average monthly price change over 6 years
Over the last 6 years, the strongest month for Azelis Group has been July: +8.38% on average, positive in 5 years out of 5. The weakest has been June: −9.24% on average, positive in 0 years out of 5. November, the current month, has been positive in 3 years out of 5 (+3.88% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | −7.35% | −10.31% | 1 of 5 |
| February | −6.50% | −3.31% | 1 of 5 |
| March | +3.14% | +3.39% | 3 of 5 |
| April | +5.76% | +7.18% | 3 of 5 |
| May | −2.82% | −0.85% | 2 of 5 |
| June | −9.24% | −8.98% | 0 of 5 |
| July | +8.38% | +4.42% | 5 of 5 |
| August | −1.91% | −6.87% | 2 of 5 |
| September | −0.19% | −2.74% | 2 of 5 |
| October | −5.19% | −5.28% | 2 of 6 |
| November | +3.88% | +1.04% | 3 of 5 |
| December | +3.18% | +3.15% | 5 of 5 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Azelis Group and its competitors
Customers in life sciences, including personal care, home care, pharmaceuticals, food and nutrition, animal nutrition, flavours and fragrances, and nutraceuticals, as well as industrial chemicals buyers in advanced materials, lubricants, metalworking fluids, electronics, textiles, leather and paper, are served by Azelis, which distributes specialty chemicals and food ingredients across Europe, the Middle East and Africa, the Americas and the Asia-Pacific region. The portfolio covers both life sciences applications and industrial chemicals, including CASE, essential and fine chemicals.
- Headquarters
- Antwerp, Belgium
- Employees
- 3,998
- Founded
- 1996
- Chief executive
- Anna Bertona
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Azelis GroupAZE | $3.25B | 7.8% | 25.7 | +12.17% |
| HEXPOLHPOL.B | $3.26B | 13.8% | 18.1 | +26.26% |
| ClariantCLN | $4.33B | 9.6% | — | +44.35% |
| Wacker ChemieWCH | $4.43B | 5.1% | — | −18.09% |
| ArkemaAKE | $4.96B | 4.6% | 234.8 | −6.54% |
| FUCHSFPE | $5.51B | 13.1% | 13.9 | +24.96% |
Same industry or related industries, similar size. Compare Azelis Group with its competitors · Full profile
